Bio-Rad Laboratories, Inc. (BIO)
NYSE: BIO · Real-Time Price · USD
371.92
-7.90 (-2.08%)
Oct 6, 2026, 1:30 PM EDT - Market open
Bio-Rad Laboratories Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Bio-Rad Laboratories stock has a consensus rating of "Hold" and an average price target of $328.33. The average 1-year stock price forecast is 11.72% lower than the current stock price, while the lowest is $280 (-24.71%) and the highest is $390 (+4.86%).
Price Target: $328.33 (-11.72%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Bio-Rad Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 1 | 1 | 1 | 1 |
| Hold | 3 | 4 | 4 | 3 | 3 | 1 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $390 | Buy | Maintains | $390 | +4.86% | Sep 28, 2026 |
| Citi | Citi | Hold Maintains $300 → $330 | Hold | Maintains | $300 → $330 | -11.27% | Aug 5, 2026 |
| Jefferies | Jefferies | Hold Maintains $275 | Hold | Maintains | $275 | -26.06% | May 21, 2026 |
Financial Forecast
Revenue This Year
2.57B
from 2.58B
Decreased by -0.53%
Revenue Next Year
2.62B
from 2.57B
Increased by 2.13%
EPS This Year
9.45
from 9.92
Decreased by -4.74%
EPS Next Year
9.92
from 9.45
Increased by 4.94%
EPS and Forward PE are based on non-GAAP adjusted numbers.